Form 8-K - Current report:
SEC Accession No. 0001213900-20-016604
Filing Date
2020-07-02
Accepted
2020-07-02 17:14:24
Documents
3
Period of Report
2020-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea123752a-8k_aytubioscience.htm 8-K 51256
2 FORM OF WAINWRIGHT WARRANT ea123752aex4-1_aytubio.htm EX-4.1 85559
3 FORM OF RESTRICTED STOCK CANCELATION AND EXCHANGE AGREEMENT ea123752aex10-1_aytubio.htm EX-10.1 53972
  Complete submission text file 0001213900-20-016604.txt   192336
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 201010774
SIC: 2834 Pharmaceutical Preparations